USC and Bodyport Remote Heart Failure Management Study
1 other identifier
interventional
39
1 country
1
Brief Summary
A feasibility study investigating the Bodyport virtual cardiac clinic vs usual care for outpatient heart failure management at Keck Medical Center of USC
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started May 2021
Typical duration for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2021
CompletedFirst Submitted
Initial submission to the registry
May 24, 2021
CompletedFirst Posted
Study publicly available on registry
July 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 5, 2024
CompletedFebruary 26, 2025
February 1, 2025
3.3 years
May 24, 2021
February 23, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Change in quality of life
Evaluating Kansas City Cardiomyopathy Questionnaire (KCCQ) measurements at the time of hospital discharge and 90-days post-discharge
Up to 14 days after enrollment and approximately 90-days post-enrollment
Scale Adherence
Measure of daily scale adherence
Through study completion, approximately 90 days
Secondary Outcomes (1)
Patient and provider satisfaction
Through study completion, approximately 90 days for patients and an average of 9 months for providers.
Study Arms (2)
BodyPort Cardiac Scale
EXPERIMENTALPatient will receive the Bodyport scale with access to Bodyport care services, such as remote monitoring, educational materials, different biomarkers detected by the scale, and online access to their data
Control
NO INTERVENTIONPatients will receive usual care and a Bodyport scale that only displays weight and weight change. No other access to care services, features, or materials will be provided during this 90 day period
Interventions
Patients will be instructed to take daily measurements for 90 days. Data will be transmitted to Bodyport and concerning findings (weight gain, change of impedance, elevated heart rate) will be reported back to the medical team. The medical team will either choose to act on the information given or continue to observe trends. Interventions may include titration of therapy, change in therapy, fluid restriction, sodium restriction and lifestyle modification
Eligibility Criteria
You may qualify if:
- Diagnosis of HFrEF or HFpEF and hospital discharge for a heart failure exacerbation within 14 days of enrollment.
- years of age or older
- English speaking
- Able to safely stand on the Bodyport scale
- Patients must have a reliable and working phone for communication with the care team
- All patients should have access to the internet via a computer or mobile device to access the Bodyport care platform
- Patients must have a safe and secure place to store the Bodyport device
You may not qualify if:
- Weight \>375 lbs.
- History of repeatedly missing follow-up appointments or being unreachable by phone
- Inability to stand on the Bodyport scale for the duration needed to capture data
- Patient in jail or currently homeless
- Known or documented noncompliance with medical therapy
- Unable to speak English
- Unable or unwilling to answer survey questions
- History of heart transplantation
- Chronic kidney disease stage IV or V and/or on hemodialysis
- Presence of a ventricular assist device
- Presence of a CardioMEMs pulmonary artery sensor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Keck Medical Center of USC
Los Angeles, California, 90033, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael W Fong, MD
Keck Medical Center of USC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Clinical Medicine
Study Record Dates
First Submitted
May 24, 2021
First Posted
July 23, 2021
Study Start
May 10, 2021
Primary Completion
September 5, 2024
Study Completion
September 5, 2024
Last Updated
February 26, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share